Prof. Dr. Fabio Piscaglia is currently working as a Full
Professor of Internal Medicine at the University of Bologna, Italy and is
Director of the Division of Internal Medicine, Hepatobiliary and Immunoallergic
Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna. He was President
of the European Federation of Societies for Ultrasound in Medicine and Biology
(EFSUMB) for the term 2011–2013. He is an Honorary Member of the Rumanian
Society of Ultrasound in Medicine. He is a member of the working group of the
American College of Radiology ACR, which released an innovative recommendation
for the characterisation and reporting of focal liver lesions at risk of
hepatocellular carcinoma in 2016, the CEUS LI-RADS classification. He actively
participated as Principal Investigator to successful grants from the NIH and
European Union and is the PI of several international sponsored trials in hepatocellular
carcinoma. His research activities have addressed questions in the field of
primary liver cancer (focusing on both diagnostic and therapeutic
interventions), liver transplantation and abdominal ultrasound, with
particular interest in innovative techniques (Doppler ultrasound, contrast
ultrasound and ultrasound elastography) and complications of liver cirrhosis.
Prof. Dr. Fabio Piscaglia is currently working as a Full
Professor of Internal Medicine at the University of Bologna, Italy and is
Director of the Division of Internal Medicine, Hepatobiliary and Immunoallergic
Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna. He was President
of the European Federation of Societies for Ultrasound in Medicine and Biology
(EFSUMB) for the term 2011–2013. He is an Honorary Member of the Rumanian
Society of Ultrasound in Medicine. He is a member of the working group of the
American College of Radiology ACR, which released an innovative recommendation
for the characterisation and reporting of focal liver lesions at risk of
hepatocellular carcinoma in 2016, the CEUS LI-RADS classification. He actively
participated as Principal Investigator to successful grants from the NIH and
European Union and is the PI of several international sponsored trials in hepatocellular
carcinoma. His research activities have addressed questions in the field of
primary liver cancer (focusing on both diagnostic and therapeutic
interventions), liver transplantation and abdominal ultrasound, with
particular interest in innovative techniques (Doppler ultrasound, contrast
ultrasound and ultrasound elastography) and complications of liver cirrhosis.